scispace - formally typeset
H

Hak Chiaw Tang

Publications -  7
Citations -  156

Hak Chiaw Tang is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications receiving 100 citations.

Papers
More filters
Journal ArticleDOI

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)

TL;DR: This study confirms that the HCM Risk-SCD model provides accurate prognostic information that can be used to target implantable cardioverter defibrillator therapy in patients at the highest risk of SCD.
Journal ArticleDOI

Markers of Focal and Diffuse Nonischemic Myocardial Fibrosis Are Associated With Adverse Cardiac Remodeling and Prognosis in Patients With Hypertension: The REMODEL Study

TL;DR: In patients with hypertension, myocardial fibrosis on cardiovascular magnetic resonance is associated with adverse cardiac remodeling and outcomes and demonstrated independent association with primary outcome.
Journal ArticleDOI

Killing two birds with one stone-MitraClip for flail P2 and systolic anterior motion of mitral valve: a case report.

TL;DR: In patients who are deemed to be at high risk for open surgery, the case demonstrated the feasibility of a percutaneous avenue, the MitraClip system, to treat not just degenerative MR, but also SAM from HOCM in a single procedure.
Journal ArticleDOI

Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis

TL;DR: Prognostic assessment of dual-biomarker combinations identified MR-proADM plus either hsTnT or NT-proBNP as the best predictive model for both clinical outcomes and should be further assessed as possibly the biomarker of choice for risk stratification in AS.
Journal ArticleDOI

TCT-698 Acute changes in mitral annular geometery after Mitraclip procedure in functional and degenerative mitral regurgitation

TL;DR: Percutaneous edge-to-edge mitral valve repair with the MitraClip device has been shown to be effective in reducing the severity of mitral regurgitation, with resultant improvements in clinical outcomes.